PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 48 filers reported holding PROTARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $907,860 | +16.8% | 290,051 | 0.0% | 0.03% | +22.7% |
Q4 2022 | $777,337 | -9.5% | 290,051 | 0.0% | 0.02% | -12.0% |
Q3 2022 | $859,000 | +1.1% | 290,051 | 0.0% | 0.02% | -7.4% |
Q2 2022 | $850,000 | -56.6% | 290,051 | -24.4% | 0.03% | -30.8% |
Q1 2022 | $1,960,000 | -65.6% | 383,526 | -54.5% | 0.04% | -11.4% |
Q4 2021 | $5,692,000 | +95.1% | 843,282 | +100.0% | 0.04% | +4.8% |
Q3 2021 | $2,918,000 | -64.5% | 421,641 | -50.0% | 0.04% | -20.8% |
Q2 2021 | $8,214,000 | +23.8% | 843,282 | +100.0% | 0.05% | -36.9% |
Q1 2021 | $6,637,000 | -55.0% | 421,642 | -30.7% | 0.08% | -46.8% |
Q4 2020 | $14,733,000 | +43.8% | 608,544 | 0.0% | 0.16% | +5.3% |
Q3 2020 | $10,242,000 | – | 608,544 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |